XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.80

-0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (7754)	11/18/1998 8:33:00 PM
From: Robert S.	Read Replies (4) of 17367

Tex, you were right on the mark with your statement: Looking at LGND and now the news from XOMA, it appears that the only thing that will awaken these sleeping dinosaurs will be actual revenue and profits. Regardless of the "proof of concept" thesis, Wall Street does not get excited about therapeutic treatments that target small markets. One should also bear in mind that LGND's pharmaceutical compound targets a market that is relatively large when viewed against meningococcemia. In light of these and other issues, the history of share price projections posted on this board can best be described as delusional.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next